Contribution of NMDA Receptor Hypofunction in Prefrontal and Cortical Excitatory Neurons to Schizophrenia-Like Phenotypes

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Rompala, Gregory R ^a,b   Zsiros, Veronika ^a   Zhang, Shuqin ^a,c   Kolata, Stefan M ^a   Nakazawa, Kazu ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Janelia Farm   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; DIZOCILPINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN GLUN1; REACTIVE OXYGEN METABOLITE; SACCHARIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN NERVE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; EXCITATORY NEURON; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GABAERGIC TRANSMISSION; GENE DELETION; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; HYPERLOCOMOTION; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; KNOCKOUT MOUSE; MALE; MOTOR DYSFUNCTION; MOUSE; NEGATIVE SYNDROME; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; POSITIVE SYNDROME; PREFRONTAL CORTEX; PREPULSE INHIBITION; PROTEIN DEFECT; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SENSORY CORTEX; SHORT TERM MEMORY; SOCIAL BEHAVIOR; SOCIAL ISOLATION; SPATIAL MEMORY; STARTLE REFLEX; TASK PERFORMANCE; WORKING MEMORY;

ANIMALS; BLOTTING, WESTERN; DIZOCILPINE MALEATE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; NEURONS; PREFRONTAL CORTEX; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

MUS;

EID: 84876160847     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061278     Document Type: Article

References (68)

1. Coyle JT, Puttfarcken P, (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
2. Javitt DC, Zukin SR, (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
3. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, et al. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
4. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA, (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25: 455-467.
5. Mohn AR, Gainetdinov RR, Caron MG, Koller BH, (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98: 427-436.
6. Volk DW, Lewis DA, (2010) Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci 4: 485-508.
7. Olney JW, Farber NB, (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52: 998-1007.
8. Jackson ME, Homayoun H, Moghaddam B, (2004) NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci U S A 101: 8467-8472.
9. Moghaddam B, Adams B, Verma A, Daly D, (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927.
10. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, et al. (2010) Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 13: 76-83.
11. Glausier JR, Lewis DA. (2012) Dendritic spine pathology in schizophrenia. Neuroscience, http://dx.doi.org/10.1016/j.neuroscience.2012.04.044.
12. Ultanir SK, Kim JE, Hall BJ, Deerinck T, Ellisman M, et al. (2007) Regulation of spine morphology and spine density by NMDA receptor signaling in vivo. Proc Natl Acad Sci U S A 104: 19553-19558.
13. Karlsgodt KH, Robleto K, Trantham-Davidson H, Jairl C, Cannon TD, et al. (2011) Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry 69: 28-34.
14. Tsien JZ, Huerta PT, Tonegawa S, (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87: 1327-1338.
15. Fukaya M, Kato A, Lovett C, Tonegawa S, Watanabe M, (2003) Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice. Proc Natl Acad Sci U S A 100: 4855-4860.
16. Iwasato T, Datwani A, Wolf AM, Nishiyama H, Taguchi Y, et al. (2000) Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex. Nature 406: 726-731.
17. Sawtell NB, Frenkel MY, Philpot BD, Nakazawa K, Tonegawa S, et al. (2003) NMDA receptor-dependent ocular dominance plasticity in adult visual cortex. Neuron 38: 977-985.
18. Berretta N, Jones RS, (1996) A comparison of spontaneous EPSCs in layer II and layer IV-V neurons of the rat entorhinal cortex in vitro. J Neurophysiol 76: 1089-1100.
19. Rebsam A, Seif I, Gaspar P, (2002) Refinement of thalamocortical arbors and emergence of barrel domains in the primary somatosensory cortex: a study of normal and monoamine oxidase a knock-out mice. J Neurosci 22: 8541-8552.
20. Dillon GM, Qu X, Marcus JN, Dodart JC, (2008) Excitotoxic lesions restricted to the dorsal CA1 field of the hippocampus impair spatial memory and extinction learning in C57BL/6 mice. Neurobiol Learn Mem 90: 426-433.
21. Matus-Amat P, Higgins EA, Sprunger D, Wright-Hardesty K, Rudy JW, (2007) The role of dorsal hippocampus and basolateral amygdala NMDA receptors in the acquisition and retrieval of context and contextual fear memories. Behav Neurosci 121: 721-731.
22. Bakshi VP, Tricklebank M, Neijt HC, Lehmann-Masten V, Geyer MA, (1999) Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. J Pharmacol Exp Ther 288: 643-652.
23. Filion DL, Poje AB, (2003) Selective and nonselective attention effects on prepulse inhibition of startle: a comparison of task and no-task protocols. Biol Psychol 64: 283-296.
24. Heekeren K, Meincke U, Geyer MA, Gouzoulis-Mayfrank E, (2004) Attentional modulation of prepulse inhibition: a new startle paradigm. Neuropsychobiology 49: 88-93.
25. Lisman JE, Fellous JM, Wang XJ, (1998) A role for NMDA-receptor channels in working memory. Nat Neurosci 1: 273-275.
26. Wang J, O'Donnell P, (2001) D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. Cereb Cortex 11: 452-462.
27. Elvevag B, Goldberg TE, (2000) Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14: 1-21.
28. Alkam T, Hiramatsu M, Mamiya T, Aoyama Y, Nitta A, et al. (2011) Evaluation of object-based attention in mice. Behav Brain Res 220: 185-193.
29. van den Buuse M, (2010) Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 36: 246-270.
30. Bigelow NO, Paradiso S, Adolphs R, Moser DJ, Arndt S, et al. (2006) Perception of socially relevant stimuli in schizophrenia. Schizophr Res 83: 257-267.
31. Carlén M, Meletis K, Siegle JH, Cardin JA, Futai K, et al. (2011) A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry 17: 537-548.
32. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M, (2009) Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19: 220-230.
33. Jiang Z, Rompala GR, Zhang S, Cowell RM, Nakazawa K (2013) Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biol Psychiat. http://dx.doi.org/10.1016/j.biopsych.2012.12.004.
34. Lewis DA, Volk DW, Hashimoto T, (2004) Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) 174: 143-150.
35. Nakazawa K, Zsiros V, Jiang Z, Nakao K, Kolata S, et al. (2012) GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 62: 1574-1583.
36. Deacon RM, Penny C, Rawlins JN, (2003) Effects of medial prefrontal cortex cytotoxic lesions in mice. Behav Brain Res 139: 139-155.
37. Gisquet-Verrier P, Delatour B, (2006) The role of the rat prelimbic/infralimbic cortex in working memory: not involved in the short-term maintenance but in monitoring and processing functions. Neuroscience 141: 585-596.
38. Niewoehner B, Single FN, Hvalby O, Jensen V, Meyer zum Alten Borgloh S, et al. (2007) Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus. Eur J Neurosci 25: 837-846.
39. Murray AJ, Sauer JF, Riedel G, McClure C, Ansel L, et al. (2011) Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory. Nat Neurosci 14: 297-299.
40. Laurent A, Saoud M, Bougerol T, d'Amato T, Anchisi AM, et al. (1999) Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives. Psychiatry Res 89: 147-159.
41. Braff DL, Geyer MA, (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47: 181-188.
42. Fendt M, Li L, Yeomans JS, (2001) Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl) 156: 216-224.
43. Li L, Yue Q, (2002) Auditory gating processes and binaural inhibition in the inferior colliculus. Hear Res 168: 98-109.
44. McDowd JM, Filion DL, Harris MJ, Braff DL, (1993) Sensory gating and inhibitory function in late-life schizophrenia. Schizophr Bull 19: 733-746.
45. Plappert CF, Kuhn S, Schnitzler HU, Pilz PK, (2006) Experience increases the prepulse inhibition of the acoustic startle response in mice. Behav Neurosci 120: 16-23.
46. Roskam S, Koch M, (2006) Enhanced prepulse inhibition of startle using salient prepulses in rats. Int J Psychophysiol 60: 10-14.
47. Li L, Du Y, Li N, Wu X, Wu Y, (2009) Top-down modulation of prepulse inhibition of the startle reflex in humans and rats. Neurosci Biobehav Rev 33: 1157-1167.
48. Mirjana C, Baviera M, Invernizzi RW, Balducci C, (2004) The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29: 1637-1647.
49. Murphy ER, Dalley JW, Robbins TW, (2005) Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task. Psychopharmacology (Berl) 179: 99-107.
50. Amitai N, Markou A, (2010) Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia. Biol Psychiatry 68: 5-16.
51. Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, et al. (2004) Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 153: 507-519.
52. Fradley RL, O'Meara GF, Newman RJ, Andrieux A, Job D, et al. (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 163: 257-264.
53. Bickel S, Lipp HP, Umbricht D, (2008) Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function. Neuropsychopharmacology 33: 1680-1689.
54. Bannerman DM, Rawlins JN, Good MA, (2006) The drugs don't work-or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-A-containing AMPA receptors to hippocampal-dependent memory. Psychopharmacology (Berl) 188: 552-566.
55. Steele RJ, Morris RG, (1999) Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus 9: 118-136.
56. MacQueen DA, Bullard L, Galizio M, (2011) Effects of dizocilpine (MK801) on olfactory span in rats. Neurobiol Learn Mem 95: 57-63.
57. Akbarian S, Huang HS, (2006) Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 52: 293-304.
58. Eyles DW, McGrath JJ, Reynolds GP, (2002) Neuronal calcium-binding proteins and schizophrenia. Schizophr Res 57: 27-34.
59. Lewis DA, Hashimoto T, Volk DW, (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6: 312-324.
60. Gil V, Bichler Z, Lee JK, Seira O, Llorens F, et al. (2010) Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon. Cereb Cortex 20: 1769-1779.
61. Jinde S, Belforte JE, Yamamoto J, Wilson MA, Tonegawa S, et al. (2009) Lack of kainic acid-induced gamma oscillations predicts subsequent CA1 excitotoxic cell death. Eur J Neurosci 30: 1036-1055.
62. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, et al. (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318: 1645-1647.
63. Lee S, Ahmed T, Kim H, Choi S, Kim DS, et al. (2012) Bidirectional modulation of fear extinction by mediodorsal thalamic firing in mice. Nat Neurosci 15: 308-314.
64. Cravens CJ, Vargas-Pinto N, Christian KM, Nakazawa K, (2006) CA3 NMDA receptors are crucial for rapid and automatic representation of context memory. Eur J Neurosci 24: 1771-1780.
65. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, et al. (2000) Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci U S A 97: 14731-14736.
66. Weisstaub NV, Zhou M, Lira A, Lambe E, Gonzalez-Maeso J, et al. (2006) Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313: 536-540.
67. Malkesman O, Scattoni ML, Paredes D, Tragon T, Pearson B, et al. (2010) The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biol Psychiatry 67: 864-871.
68. Hauser TA, Kucinski A, Jordan KG, Gatto GJ, Wersinger SR, et al. (2009) TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem Pharmacol 78: 803-812.